Terrie Curran, Director: Arcutis Biotherapeutics ARQT Planned sale · Filed 08/20

Trade details

Type: Planned sale notice
Stock: Arcutis Biotherapeutics ARQT
Person: Terrie CurranDirector
Planned sale date: 26/08/20
Filed: 26/08/20

$27.9K to be sold

Arcutis Biotherapeutics trades, last 26 weeks

What else happened in Arcutis Biotherapeutics around then

Filed or reported within 30 days of the trade day · 07/21~09/19

Terrie Curran's recent trades

Terrie CurranDirector
Planned saleArcutis Biotherapeutics
Planned sale
Arcutis Biotherapeutics
ARQT
$956.1K
38,200 sh
$956.1K
Filed 08/27
Traded 08/27
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$125.9K
19,109 sh
$125.9K
Filed 25/01/23
Traded 25/01/21
Terrie CurranDirector
SellArcutis Biotherapeutics
Sell
Arcutis Biotherapeutics
ARQT
$94.3K
8,687 sh
$94.3K
Filed 24/11/13
Traded 24/11/11
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$396.7K
33,848 sh
$396.7K
Filed 24/07/17
Traded 24/07/15
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$153.5K
16,851 sh
$153.5K
Filed 24/03/26
Traded 24/03/22

Terrie Curran, Director — plans to sell 1,072 sh of Arcutis Biotherapeutics ARQT · $27.9K · around 08/20 | Whalegun